Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases

Latrepirdine (Dimebon(TM)) was originally marketed as a non-selective antihistamine in Russia. It was repurposed as an effective treatment for patients suffering from Alzheimer's disease (AD) and Huntington's disease (HD) following preliminary reports showing its neuroprotective functions...

Descripción completa

Detalles Bibliográficos
Autores principales: Bharadwaj, P R, Bates, K A, Porter, T, Teimouri, E, Perry, G, Steele, J W, Gandy, S, Groth, D, Martins, R N, Verdile, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030329/
https://www.ncbi.nlm.nih.gov/pubmed/24301650
http://dx.doi.org/10.1038/tp.2013.97

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030329/
https://www.ncbi.nlm.nih.gov/pubmed/24301650
http://dx.doi.org/10.1038/tp.2013.97

Ejemplares similares